Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALMKT.PA
- Price
- 0.07
- Stock movement down
- -0.01 (-7.63%)
- Company name
- Mauna Kea Technologies SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 6.20M
- Ent value
- 44.92M
- Price/Sales
- 0.49
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -21.55%
- 1 year return
- -56.27%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-24
DIVIDENDS
ALMKT.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.49 |
| Price to Book | - |
| EV to Sales | 3.56 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 83.88M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.92M |
| Net receivables | 1.47M |
| Total current assets | 9.04M |
| Goodwill | 0.00 |
| Intangible assets | 1.47M |
| Property, plant and equipment | 10.96M |
| Total assets | 16.25M |
| Accounts payable | 3.27M |
| Short/Current long term debt | 31.93M |
| Total current liabilities | 33.37M |
| Total liabilities | 40.63M |
| Shareholder's equity | -24.39M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.08 |
| Daily high | 0.08 |
| Daily low | 0.07 |
| Daily Volume | 2.98M |
| All-time high | 17.75 |
| 1y analyst estimate | 1.00 |
| Beta | 0.82 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALMKT.PA | S&P500 | |
| Current price drop from All-time high | -99.58% | -2.71% |
| Highest price drop | -99.58% | -19.00% |
| Date of highest drop | 24 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -99.20% | -2.73% |
| Avg time to new high | - | 6 days |
| Max time to new high | 288 days | 89 days |
COMPANY DETAILS
Marketcap
6.20M
Marketcap category
Small-cap
Description
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Employees
61
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
PARIS & BOSTON, November 20, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy ...
November 20, 2025
PARIS & BOSTON, November 14, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (the "Company"), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser...
November 14, 2025
PARIS & BOSTON, November 13, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy ...
November 13, 2025
PARIS, November 06, 2025--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):
November 6, 2025
PARIS & BOSTON, October 21, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
October 21, 2025
PARIS & BOSTON, October 13, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
October 13, 2025
PARIS & BOSTON, October 08, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
October 8, 2025
PARIS & BOSTON, October 06, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT):
October 6, 2025
PARIS & BOSTON, October 01, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
October 1, 2025
PARIS & BOSTON, September 22, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), (the "Company") inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal lase...
September 22, 2025
Next page